At-home, do-it-yourself swabs allowed accurate detection of HPV and other STIs among women overdue for cervical cancer testing.
Cervical cancer screening has been largely successful in the U.S., yet pockets of underscreened (mostly low-income) women remain. To investigate the acceptability and validity of human papillomavirus (HPV) testing among women overdue for cervical cancer screening (no Pap testing within the past 4 years), researchers in North Carolina invited 284 women (age range, 30–64) to self-test at home with a mail-in cervicovaginal brush and kit designed for the purpose, then to attend a clinic visit for another self-collected sample and a clinician-collected sample.
Detection of high-risk HPV (as well as gonorrhea, chlamydia, Trichomonas vaginalis, and Mycoplasma genitalium) showed high concordance for mail-in self-swabs, clinic-collected self-swabs, a…
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)